Ivermectin is an antiparasitic medication that may potentially modulate neurological symptoms through its action on GABA receptors and glutamate signaling pathways. While not a primary treatment for Depersonalization-derealization disorder, some preliminary research suggests it might help reduce neuroinflammation and potentially alleviate dissociative symptoms by influencing neural circuit functioning. However, its use for DPDR remains experimental and requires further clinical investigation.